Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 4, 2025

Immunohistochemical Expression of CaSR, VDR, and AMA in Parathyroid Tumors Linked to Hypercalcemia Severity in Primary Hyperparathyroidism

View Full Paper
Ask AI
Bookmark
Share

Authors

AEAnna EremkinaDPDariya A. PastuhovaАМА. П. Милютина

Discussion

Loading...

Member takes

Overview

Retrospective study found no correlation between CaSR or VDR expression and hypercalcemia severity in parathyroid tumors, suggesting alternative molecular mechanisms.

Key Points

  • MAIN FINDING: CaSR expression was strong in 95.8% of parathyroid tumors; however, VDR expression was reduced in nearly half of the cases.
  • KEY EVIDENCE: No significant differences in the expression of CaSR, VDR, or AMA were observed across various hypercalcemia severity groups.
  • APPROACH: Study analyzed 96 patients who had parathyroidectomy and used immunohistochemical methods to assess protein expressions.
  • SIGNIFICANCE: Findings indicate that receptor expression levels may not fully explain clinical variability in primary hyperparathyroidism severity.

Cite This Study

Eremkina et al. (2025) studied this question.

synapsesocial.com/papers/689a0f8de6551bb0af8d0e30https://doi.org/10.21203/rs.3.rs-6811379/v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Receptor gene expressions and their association with biochemical parameters in primary hyperparathyroidism patients2025
  2. 2Can vitamin D supplementation be dangerous? 25-Hydroxyvitamin D and 1,25-hydroxyvitamin D concentration in healthy population and primary hyperparathyroidism: a single-center experience and literature review2025 · 1 citations
  3. 3Role of vitamin D receptor and calcium sensing receptor in parathyroid cancer2026
  4. 4A-075 Distinguishing Secondary Hyperparathyroidism from Early Normocalcemic Primary Hyperparathyroidism: Does Selection of Reference Change Values Change the Clinical Significance of Diagnostic Outcomes?2025
  5. 5Temporal Variation of Biochemical Markers and Adenoma Predictors in Normocalcemic Primary Hyperparathyroidism: A Multicenter Retrospective Analysis2025 · 2 citations